ロード中...
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing
Chimeric antigen receptor (CAR)-expressing T cells are a promising therapeutic option for patients with cancer. We developed a new CAR directed against the disialoganglioside GD2, a surface molecule expressed in neuroblastoma and in other neuroectoderm-derived neoplasms. The anti-GD2 single-chain va...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4694800/ https://ncbi.nlm.nih.gov/pubmed/26298772 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|